Geron
GERN • NASDAQ
Geron is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Harout Semerjian, with a market cap of $1.1B.
Market Cap$1.1B
Employees141.0
CEOHarout Semerjian
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Geron FAQ
Common questions about Geron
Geron is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $50.2M.
Geron has approximately 141 employees.